Atara Biotherapeutics (ATRA) Financials: Revenue & Earnings
$85.77M
Market Cap
-7.28
P/E
9.08
Forward P/E
50
Score
ATRA price $8.54 +0.24 +2.95%
Stocklytics score rationale: value 60, quality 42, growth 48.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 20340000 | 63573000 | 8573000 | 128940000 | 120772000 |
Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candidate, tabelecleucel, is currently undergoing Phase 3 clinical trials for…
ATRA fair value $36.83. Price $8.54. Price is 77% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.13 | — | 800.00K |
| 2026-08-12 | -0.32 | -0.32 | 630.00K | 550.00K |
| 2026-05-14 | -0.29 | -0.33 | 516.00K | 2.90M |
| 2026-03-16 | -0.25 | -0.09 | 1.64M | 3.37M |
| 2025-11-12 | -0.32 | -0.83 | 3.45M | 700.00K |
| 2025-08-11 | 0.19 | -0.32 | 17.57M | 1.80M |
| 2025-05-15 | 3.50 | -3.07 | 98.15M | 4.30M |
| 2025-03-07 | -1.19 | -3.82 | 32.75M | 20.58M |
| 2024-11-12 | -2.93 | -3.77 | 40.19M | 33.09M |
| 2024-08-12 | -3.10 | -1.25 | 28.64M | 39.99M |
| 2024-05-09 | -5.75 | -9.25 | 27.36M | 24.69M |
| 2024-03-28 | -14.00 | -15.25 | 4.25M | 11.55M |
| 2023-11-01 | -16.50 | -15.75 | 2.14M | 4.76M |
| 2023-08-08 | -17.00 | -16.25 | 957.00K | 3.77M |
| 2023-05-08 | -18.00 | -10.00 | 1.23M | 30.68M |
| 2023-02-08 | -18.00 | -15.25 | 221.00K | 34.01M |
| 2022-11-08 | -20.50 | -19.50 | 4.46M | 5.13M |
| 2022-08-08 | 0.18 | -19.90 | 51.58M | 6.84M |
| 2022-05-05 | -21.75 | -0.98 | 7.31M | 5.79M |
| 2022-02-28 | -0.96 | -15.00 | 7.55M | 31.38M |
| 2021-11-04 | -22.50 | -23.00 | 5.37M | 3.49M |
| 2021-08-09 | -22.75 | -22.00 | 3.87M | 3.84M |
| 2021-05-04 | -21.50 | -23.25 | 3.55M | 3.78M |
| 2021-03-01 | -23.75 | -18.25 | 358.19M | — |
| 2020-11-09 | -23.00 | -27.50 | — | — |
| 2020-08-05 | -28.50 | -30.25 | — | — |
| 2020-05-06 | -30.00 | -34.00 | — | — |
| 2020-02-27 | -34.00 | -32.50 | — | — |
| 2019-11-07 | -32.75 | -35.00 | — | — |
| 2019-08-08 | -40.00 | -36.25 | — | — |
| 2019-05-09 | -36.00 | -37.00 | — | — |
| 2019-02-26 | -43.75 | -32.75 | — | — |
| 2018-11-06 | -32.25 | -29.50 | — | — |
| 2018-08-01 | -28.75 | -24.25 | — | — |
| 2018-05-08 | -26.25 | -23.25 | — | — |
| 2018-02-27 | -28.75 | -28.75 | — | — |
| 2017-11-09 | -25.50 | -25.75 | — | — |
| 2017-08-07 | -23.50 | -22.75 | — | — |
| 2017-05-04 | -22.00 | -19.25 | — | — |
| 2017-03-09 | -15.75 | -22.75 | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Cherry Brian N | Buy | 104.17K | $9.60 | 999.99K |
| 2026-08-17 | Nguyen AnhCo | Sell | 5.06K | $8.08 | 40.88K |
| 2026-07-22 | Redmile Group, LLC | Buy | 195.21K | — | — |
| 2026-07-22 | Redmile Group, LLC | Sell | 60 | — | — |
| 2026-07-22 | Redmile Group, LLC | Sell | 55.39K | $0.00 | 138 |
| 2026-06-26 | Sarney Kevin G | Other | 0 | — | — |
| 2026-06-11 | Cherry Brian N | Buy | 24.00K | — | — |
| 2026-06-11 | Cherry Brian N | Other | 0 | — | — |
| 2026-06-09 | HEIDEN WILLIAM K | Buy | 12.00K | — | — |
| 2026-06-09 | Fust Matthew K | Buy | 12.00K | — | — |
| 2026-06-09 | Ciongoli Gregory Austin | Buy | 12.00K | — | — |
| 2026-05-18 | Nguyen AnhCo | Sell | 5.24K | $9.13 | 47.84K |
| 2026-05-18 | Grant-Huerta Yanina | Sell | 2.41K | $9.13 | 22.04K |
| 2026-05-07 | Panacea Innovation Ltd | Sell | 313.45K | $10.10 | 3.17M |
| 2026-05-07 | EcoR1 Capital, LLC | Buy | 507.41K | $9.35 | 4.74M |
| 2026-05-07 | EcoR1 Capital, LLC | Other | 0 | — | — |
| 2026-03-17 | Panacea Innovation Ltd | Buy | 259.16K | $0.00 | 26 |
| 2026-03-17 | Panacea Innovation Ltd | Sell | 5 | $5.23 | 26 |
| 2026-03-17 | Panacea Innovation Ltd | Sell | 259.16K | $0.00 | 26 |
| 2026-03-09 | Nguyen AnhCo | Buy | 81.10K | — | — |
| 2026-03-09 | Grant-Huerta Yanina | Buy | 20.30K | — | — |
| 2026-03-02 | Grant-Huerta Yanina | Sell | 24 | $5.08 | 122 |
| 2026-03-02 | Grant-Huerta Yanina | Sell | 1.60K | $5.08 | 8.14K |
| 2026-03-02 | Grant-Huerta Yanina | Sell | 377 | $5.08 | 1.92K |
| 2026-03-02 | Grant-Huerta Yanina | Sell | 100 | $5.08 | 508 |
| 2026-03-02 | Nguyen AnhCo | Sell | 198 | $5.08 | 1.01K |
| 2026-03-02 | Nguyen AnhCo | Sell | 58 | $5.08 | 295 |
| 2026-03-02 | Nguyen AnhCo | Sell | 1.30K | $5.09 | 6.60K |
| 2026-03-02 | Nguyen AnhCo | Sell | 1.44K | $5.09 | 7.34K |
| 2026-01-12 | Panacea Innovation Ltd | Sell | 80.55K | $6.07 | 489.02K |
| 2025-11-28 | Panacea Innovation Ltd | Sell | 48.74K | $0.00 | 5 |
| 2025-11-28 | Panacea Innovation Ltd | Buy | 48.74K | $0.00 | 5 |
| 2025-11-28 | Panacea Innovation Ltd | Sell | 1 | $14.03 | 14 |
| 2025-11-17 | Nguyen AnhCo | Sell | 2.86K | $13.19 | 37.70K |
| 2025-11-17 | Nguyen AnhCo | Sell | 56 | $13.19 | 739 |
| 2025-11-17 | Grant-Huerta Yanina | Sell | 1.65K | $13.19 | 21.69K |
| 2025-11-17 | Grant-Huerta Yanina | Sell | 85 | $13.19 | 1.12K |
| 2025-11-17 | Grant-Huerta Yanina | Sell | 74 | $13.19 | 976 |
| 2025-08-18 | Nguyen AnhCo | Sell | 57 | $11.61 | 662 |
| 2025-08-18 | Nguyen AnhCo | Sell | 1.28K | $11.62 | 14.88K |
| 2025-08-18 | Nguyen AnhCo | Sell | 1.62K | $11.62 | 18.82K |
| 2025-08-18 | Grant-Huerta Yanina | Sell | 55 | $11.61 | 638 |
| 2025-08-18 | Grant-Huerta Yanina | Sell | 86 | $11.61 | 999 |
| 2025-08-18 | Grant-Huerta Yanina | Sell | 1.67K | $11.61 | 19.37K |
| 2025-08-15 | Panacea Innovation Ltd | Buy | 55.00K | $12.19 | 670.42K |
| 2025-07-17 | Panacea Innovation Ltd | Buy | 19.34K | $9.64 | 186.37K |
| 2025-06-10 | Gallagher Carol Giltner | Buy | 7.83K | — | — |
| 2025-06-10 | Fust Matthew K | Buy | 7.83K | — | — |
| 2025-06-10 | Touchon Pascal | Buy | 7.83K | — | — |
| 2025-06-10 | Roncarolo Maria Grazia | Buy | 7.83K | — | — |
| 2025-06-10 | MALLIK AMEET | Buy | 7.83K | — | — |
| 2025-06-10 | HEIDEN WILLIAM K | Buy | 7.83K | — | — |
| 2025-05-16 | Subramanian Nachiappan | Other | 0 | — | — |
| 2025-05-16 | Redmile Group, LLC | Other | 0 | — | — |
| 2025-05-16 | Redmile Group, LLC | Other | 4.87K | $9.31 | 45.38K |
| 2025-05-16 | Redmile Group, LLC | Other | 3.41M | — | — |
| 2025-05-16 | Redmile Group, LLC | Other | 4.10K | $809.86 | 3.32M |
| 2025-05-16 | Panacea Innovation Ltd | Other | 0 | — | — |
| 2025-05-16 | Panacea Innovation Ltd | Other | 307.90K | $0.00 | 31 |
| 2025-05-16 | Grant-Huerta Yanina | Sell | 2.22K | $6.76 | 15.00K |
| 2025-05-16 | Nguyen AnhCo | Sell | 3.28K | $6.76 | 22.16K |
| 2025-05-16 | Adiumentum Capital Fund I LP | Buy | 75.57K | $6.61 | 499.53K |
| 2025-05-16 | Adiumentum Capital Fund I LP | Buy | 227.00K | $0.00 | 23 |
| 2025-03-31 | Grant-Huerta Yanina | Other | 0 | — | — |
| 2025-03-31 | Grant-Huerta Yanina | Other | 550 | $97.75 | 53.76K |
| 2025-03-31 | Hyllengren Eric J | Sell | 8.96K | $97.75 | 875.94K |
| 2025-03-31 | Hyllengren Eric J | Sell | 543 | $255.25 | 138.60K |
| 2025-03-31 | Hyllengren Eric J | Sell | 262 | $255.25 | 66.88K |
| 2025-03-31 | Hyllengren Eric J | Sell | 460 | $961.75 | 442.40K |
| 2025-03-31 | Hyllengren Eric J | Sell | 331 | $97.75 | 32.36K |
| 2025-03-31 | Hyllengren Eric J | Sell | 154 | $303.75 | 46.78K |
| 2025-03-31 | Hyllengren Eric J | Sell | 1.90K | $996.25 | 1.89M |
| 2025-03-31 | Hyllengren Eric J | Sell | 350 | $427.63 | 149.67K |
| 2025-03-03 | Nguyen AnhCo | Sell | 3.33K | $7.00 | 23.31K |
| 2025-03-03 | Hyllengren Eric J | Sell | 1.21K | $7.00 | 8.47K |
| 2025-03-03 | Henrich Jill | Sell | 1.06K | $7.00 | 7.41K |
| 2025-01-27 | Hyllengren Eric J | Buy | 34.05K | — | — |
| 2024-11-18 | Henrich Jill | Sell | 1.00K | $11.20 | 11.20K |
| 2024-11-18 | Hyllengren Eric J | Sell | 1.36K | $11.20 | 15.27K |
| 2024-11-18 | Nguyen AnhCo | Sell | 1.66K | $11.20 | 18.63K |
| 2024-09-09 | Nguyen AnhCo | Buy | 45.00K | — | — |
| 2024-09-03 | Adiumentum Capital Fund I LP | Sell | 0 | — | — |
| 2024-09-03 | Adiumentum Capital Fund I LP | Sell | 150.19K | $0.00 | 15 |
| 2024-08-16 | Touchon Pascal | Sell | 2.76K | $6.63 | 18.31K |
| 2024-08-16 | Touchon Pascal | Sell | 276 | $6.63 | 1.83K |
| 2024-08-16 | Nguyen AnhCo | Sell | 1.47K | $6.63 | 9.73K |
| 2024-08-16 | Nguyen AnhCo | Sell | 297 | $6.63 | 1.97K |
| 2024-08-16 | Nguyen AnhCo | Sell | 56 | $6.63 | 371 |
| 2024-08-16 | Murugan Amar | Sell | 877 | $6.63 | 5.81K |
| 2024-08-16 | Murugan Amar | Sell | 192 | $6.63 | 1.27K |
| 2024-08-16 | Murugan Amar | Sell | 89 | $6.63 | 590 |
| 2024-08-16 | Hyllengren Eric J | Sell | 1.04K | $6.63 | 6.90K |
| 2024-08-16 | Hyllengren Eric J | Sell | 29 | $6.63 | 192 |
| 2024-08-16 | Henrich Jill | Sell | 831 | $6.63 | 5.51K |
| 2024-08-16 | Henrich Jill | Sell | 132 | $6.63 | 875 |
| 2024-08-12 | Touchon Pascal | Sell | 7.08K | $427.63 | 3.03M |
| 2024-08-12 | Touchon Pascal | Sell | 9.68K | $303.75 | 2.94M |
| 2024-08-12 | Touchon Pascal | Sell | 9.00K | $510.75 | 4.60M |
| 2024-07-31 | Grant-Huerta Yanina | Other | 275 | $11.00 | 3.02K |
| 2024-05-16 | Touchon Pascal | Sell | 81.51K | $0.62 | 50.29K |
Latest filed quarter: Q2 2026.
Institutions holding: 36, holders +2 vs prior quarter. Ownership 29.72%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 1.55M | 1.45M | +1458.34% | 17.82M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 850.00K | 150.00K | +21.43% | 9.76M |
| POINT72 ASSET MANAGEMENT, L.P. | 687.72K | 493.45K | +254.01% | 7.90M |
| REDMILE GROUP, LLC | 441.70K | 0 | 0.00% | 5.07M |
| VANGUARD CAPITAL MANAGEMENT LLC | 247.05K | 29.18K | +13.40% | 2.84M |
| MACKENZIE FINANCIAL CORP | 233.25K | -80.37K | -25.63% | 2.68M |
| BLACKROCK, INC. | 84.45K | 5.43K | +6.88% | 969.54K |
| GEODE CAPITAL MANAGEMENT, LLC | 75.13K | 8.98K | +13.58% | 862.92K |
| STALEY CAPITAL ADVISERS INC | 50.00K | 0 | 0.00% | 574.00K |
| VANGUARD FIDUCIARY TRUST CO | 43.04K | 9.41K | +28.00% | 494.05K |
| ACADIAN ASSET MANAGEMENT LLC | 38.84K | -92.06K | -70.33% | 444.00K |
| JANE STREET GROUP, LLC | 30.34K | -3.52K | -10.41% | 348.36K |
| STATE STREET CORP | 26.45K | 0 | 0.00% | 303.68K |
| NORTHERN TRUST CORP | 16.59K | 4.25K | +34.45% | 190.47K |
| FMR LLC | 16.24K | 0 | 0.00% | 186.41K |
| XTX TOPCO LTD | 15.30K | 15.30K | New | 175.68K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 14.00K | -18.69K | -57.17% | 160.72K |
| MILLENNIUM MANAGEMENT LLC | 12.68K | -35.01K | -73.41% | 145.57K |
| CITADEL ADVISORS LLC | 10.16K | 10.16K | New | 116.62K |
| MORGAN STANLEY | 9.18K | 9 | +0.10% | 105.37K |
| ROYAL BANK OF CANADA | 4.74K | 424 | +9.82% | 55.00K |
| UBS GROUP AG | 3.98K | -46.09K | -92.05% | 45.68K |
| VANGUARD GLOBAL ADVISERS, LLC | 1.46K | 0 | 0.00% | 16.71K |
| SBI SECURITIES CO., LTD. | 1.40K | -170 | -10.80% | 16.12K |
| JONES FINANCIAL COMPANIES LLLP | 803 | 100 | +14.22% | 8.44K |
Atara Biotherapeutics, Inc. (ATRA) trades at $8.54, with a market cap of $85.77M and a trailing P/E of -7.28. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 20340000 | 63573000 | 8573000 | 128940000 | 120772000 |
Insights · Dividends · Forecast · Financials · Learn
$85.77M
Market Cap
-7.28
P/E
9.08
Forward P/E
50
Score